You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Community Videos on Diabetes Health TV
Close Encounter - A Profile of a Diabetes Patient and Business Insider
The World's First Diabetes Emergency Kit
Author Dispels Diabetes Myths
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza (liraglutide injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
4 comments - Jan 28, 2010 -
Denmark-based Novo Nordisk A/S has begun phase 1 testing of an insulin pill that, if successful, could replace injections as the primary means of blood sugar control for millions of people with type 1 and type 2 diabetes. The company has enrolled 80 volunteer German test subjects in the study and expects to have preliminary results by the first half of 2011. The test group consists of both people with diabetes and people without it.
12 comments - Dec 24, 2009 -
PRINCETON, NJ (November 27, 2009) - The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.
5 comments - Nov 27, 2009 -
PRINCETON, N.J., Nov. 19 /PRNewswire/ -- Nearly one-third of doctors surveyed said they did not have enough time and did not receive sufficient reimbursement to provide comprehensive care to their patients with diabetes, according to the results of a study of endocrinologists and primary care doctors published in American Health & Drug Benefits.
4 comments - Nov 20, 2009 -
The enthusiasm for inhaled insulin has waned, to say the least, since Exubera was pulled off the market by Pfizer. Following the Exubera debacle, the development of two other inhaled insulins (AIR by Eli Lilly and Alkermes, and AERx by Novo Nordisk) was halted as well.
14 comments - Oct 5, 2009 -
ALEXANDRIA, VA, Sep 01, 2009 (MARKETWIRE via COMTEX) - The American Diabetes Association Research Foundation has selected two scientists, University of Virginia Health System researcher Zhenqi Liu, MD, and Stanford University School of Medicine researcher Gerald Reaven, MD, to receive the American Diabetes Association-Novo Nordisk Clinical/Translational Research Award.
0 comments - Sep 12, 2009 -
Three days after a routine physical last November, 84-year-old Louis Zorich was called by his doctor and told that he had type 2 diabetes. The first words out of the seasoned actor's mouth were "There's been a mistake." Louis, who's been married to Academy Award-winning actress Olympia Dukakis for 47 years, proceeded to explain (incorrectly) to his doctor, "Men don't get diabetes. My three brothers don't have it, but my mother had it....It may be genetic, but only the female side of my family can have diabetes."
2 comments - Aug 21, 2009 -
Until the twentieth century, type 1 diabetes was a fatal disease. Once we came to understand how insulin works in the body, however, everything changed. The discovery of the role of insulin was a group effort by people who didn't know each other, but built on each others' work. In 1869, a German medical student named Paul Langerhans figured out the regulatory role of insulin in the mammal body. In honor of his efforts, his name was given to the islets of Langerhans, where insulin is synthesized within the beta cells of the pancreas. Other Europeans and North Americans made important advancements right up until January 23, 1922, when a 14-year-old boy who was dying of diabetes at Toronto General Hospital was given the first successful injection of cow insulin.
2 comments - Aug 10, 2009 -
Last May, 24-year-old Charlie Kimball was in Car #35, taking Turn 3 at the Indianapolis Motor Speedway during the Firestone Freedom 100. He was in radio contact with his pit crew, who informed him that he had a headwind coming out of the turn and onto the 5/8 mile "straight." Charlie kept an eye on the car next to him, moving closer and beginning to crowd it on the inside. Having raced professionally for six years, he knew that he had to make a move, and soon. He shifted into sixth gear and accelerated.
2 comments - Aug 8, 2009 -
Most clinical studies of new drugs are conducted primarily on white men, whether or not they are most affected by the disease the drug is intended to treat. African Americans, for example, are 1.6 times more likely to have diabetes than non-Hispanic whites. Why should we assume that what works for white males will also be effective for African Americans, Hispanics, Asians, or, for that matter, women?
0 comments - Aug 7, 2009 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.